Håvard Hildeng Hauge, CEO of PubGene, has directed activities at the company since 2004 and has previous corporate experience as managing director of Biomolex. Hauge is also an accomplished scientist. He received his Ph.D. in biochemistry from the University of Oslo in 1999 for his work on protein structures in relation to membrane permeability in lactic acid bacteria. Dr. Hauge continued this work in a postdoctoral position including one year at EMBL, Heidelberg. His scientific efforts have thus far resulted in several publications in international journals.
Tor-Kristian Jenssen, Head of Research and Development, holds MSc and Ph.D degrees in Computer Sciences. He lectured Informatics at the Norwegian Institute of Technology in 1998 – 1999, was a researcher in the Norwegian Cancer Hospital in 2001 – 2002, and a Board member of two strategic programs at the Norwegian Institute of Technology.